Melanoma Clinical Trials in Pennsylvania

Showing 81-100 of 146 trials

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

NCT00003308

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiation therapy in treating patients with newly diagnosed brain metastases from kidney cancer, melanoma, or sarcoma.

Kidney CancerMelanoma (Skin)Metastatic Cancer+2 more

Eastern Cooperative Oncology GroupStarted Feb 1999

Des Moines, Iowa, United States • Des Moines, Iowa, United States • Des Moines, Iowa, United States +11 more locations

COMPLETEDPHASE390 miles

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

NCT02714218

The purpose of this study is to evaluate two different dose combinations of nivolumab and ipilimumab in the treatment of melanoma.

Melanoma

Bristol-Myers Squibb387 participantsStarted Apr 2016

Aurora, Colorado, United States • Tampa, Florida, United States • Fridley, Minnesota, United States +54 more locations

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

Melanoma Trials in Other Cities

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Safety Study of MGA271 in Refractory Cancer

A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Safety Study of SEA-CD40 in Cancer Patients

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies

Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors

Engaging Moms on Teen Indoor Tanning Through Social Media

A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma

Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma

Other Conditions in Pennsylvania